In this episode, we review the latest 2026 Consensus Statement recommendations for the evaluation and management of prediabetes. Topics include updated diagnostic criteria, the recognition of prediabetes as a cardiometabolic disease state, lifestyle interventions as the foundation of therapy, and strategies to prevent progression to type 2 diabetes. We also discuss comprehensive cardiovascular risk reduction, weight loss goals, the role of anti obesity medications and bariatric surgery, evaluation of lean prediabetes, pharmacologic options for diabetes risk reduction, and key clinical pearls for optimizing long term patient outcomes. Learn how early identification and comprehensive management can reduce future diabetes and cardiovascular disease burden.